Research progress and clinical prospect of immunocytotherapy for the treatment of hepatocellular carcinoma
- 3 March 2020
- journal article
- review article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 82, 106351
- https://doi.org/10.1016/j.intimp.2020.106351
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- A Clinical Study of HBsAg‐Activated Dendritic Cells and Cytokine‐Induced Killer Cells During the Treatment for Chronic Hepatitis BScandinavian Journal of Immunology, 2013
- Cytokine-induced killer cells promote antitumor immunityJournal of Translational Medicine, 2013
- Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing ProtocolFrontiers in Oncology, 2013
- Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastomaBlood, 2011
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patientsJCI Insight, 2011
- Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade culturesJournal of Translational Medicine, 2010
- Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of CancerJournal of Biomedicine and Biotechnology, 2010
- Minimally Cultured Tumor-infiltrating Lymphocytes Display Optimal Characteristics for Adoptive Cell TherapyJournal of Immunotherapy, 2008
- Partial Reduction of Human FOXP3+ CD4 T Cells In Vivo After CD25-directed Recombinant Immunotoxin AdministrationJournal of Immunotherapy, 2008
- DDVP markedly decreases the expression of granzyme B and granzyme 3/K in human NK cellsToxicology, 2008